Analysts BMO Capital Markets initiated coverage of RXO (RXO) with an outperform rating and a $35 target price, indicating 29% upside
BMO Capital Markets has initiated coverage of RXO with an 'outperform' rating and a $35 price target, indicating a potential 29% upside, as the truckload market tightens and RXO's operational metrics improve significantly.